Generer rapport
Danaher Medical Aps
Åkandevej 21, c/o Radiometer Medical ApS, 2700 Brønshøj, CVR 27559522
Virksomhedsform
Anpartsselskab
Etableret
2004
Størrelse
Mikro
Ansatte
-
Omsætning
219
MDKK
Bruttofortj.
218
MDKK
Primært resultat (EBIT)
92
MDKK
Årets resultat
75
MDKK
Egenkapital
890
MDKK
annonce
Flere nøgletal og analyser?
Med en Bisbase Premium konto får du flere nøgletal for både virksomheder, koncerner og brancher samt adgang til eksklusive brancher indeholdende virksomheder nøje sammensat af eksperter. Og vil du lave dine egne analyser kan du også det! Det tager få minutter at få adgang - og det behøver ikke at koste dig noget!
Rang Årets resultat
Rang i branche
4/252
"Top 10%"
Rang i Danmark
2.085/343.300
"Top 10%"
Direktion top 3
| Frank Talbot McFaden 1 | CEO |
| Melanie Hammerschmidt-Broman 2 | Direktør |
| Michael Reinholt Andersen 2 | Direktør |
Legale ejere top 3
| 100% | Radiometer Medical Aps | DK |
Tegningsregler
Selskabet tegnes af en direktør.
Stamoplysninger baseret på CVR
| Navn | Danaher Medical Aps |
| CVR | 27559522 |
| Adresse | Åkandevej 21, c/o Radiometer Medical ApS, 2700 Brønshøj |
| Branche | Leasing af intellektuelle ejendomsrettigheder og lignende, dog ikke ophavsretsbeskyttede værker [774000] |
| Etableret | 23-01-2004 (20 år) |
| Første regnskabsperiode | 23-01-2004 til 30-04-2004 |
| Virksomhedsform | Anpartsselskab |
| Antal ansatte | - |
| Reklamebeskyttelse | Nej |
| Revisor | Ey Godkendt Revisionspartnerselskab siden 10-10-2014 |
| Regnskabsperiode | 01-01 til 31-12 |
| Selskabskapital | 127.000 DKK 126.000 DKK (27-10-2008 - 06-12-2009) 125.000 DKK (23-01-2004 - 26-10-2008) |
| Vedtægter seneste | 30-04-2015 |
Medlem af brancherne
- Leasing af intellektuelle ejendomsrettigheder og lignende, dog ikke ophavsretsbeskyttede værkerNACE6 indeholdende 310 virk.
- Leasing af intellektuelle ejendomsrettigheder og lignende, dog ikke ophavsretsbeskyttede værkerNACE3 indeholdende 310 virk.
- Udlejning og leasingNACE2 indeholdende 5.966 virk.
- Administrative tjenesteydelser og hjælpetjenesterNACE1 indeholdende 38.318 virk.
Formål
Selskabets formål er, direkte eller indirekte, at drive virksomhed i ind- og udland ved industri, handel, finansiering, investering og anden hermed i forbindelse stående virksomhed.
Regnskab
| 2023 | 2022 | 2021 | |
|---|---|---|---|
| Valuta/enhed | 000' DKK | 000' DKK | 000' DKK |
| Omsætning | 218.678 +5% | 208.581 +8% | 192.957 +4% |
| Bruttofortjeneste | 218.092 +5% | 208.016 +8% | 192.360 +4% |
| Årets resultat | 75.368 +15% | 65.737 +17% | 55.991 +5% |
| Egenkapital | 890.267 -12% | 1.014.898 -12% | 1.149.160 -32% |
| Balance | 1.104.051 -12% | 1.252.775 -11% | 1.410.044 -29% |
Ledelsesberetning
Development in activities and financial position
The Company's income statement for the period January 1 - December 31, 2023 shows a net profit of DKK 75.368 thousand, and the balance sheet at December 31, 2023 shows equity of DKK 890.267 thousand. Income relates to licensing of the acquired intangible fixed assets and the result for the year is considered satisfactory. In the financial statements for 2022 management expected profit/loss for 2023 to be within a margin of +/- 10% compared to 2022. Profit for the year increased 15% compared to 2022 as a result of increased revenue from royalties due to increased sales by Radiometer Medical ApS in 2023. This is caused by an increase in the number of units sold with the intellectual property. Currency adjustments has slightly positivly affected the revenue from royalty. The development is considered satisfactory. The Board of Executives recommends distibution of the profit as stated under proposed distribution of profit.
The Company's income statement for the period January 1 - December 31, 2023 shows a net profit of DKK 75.368 thousand, and the balance sheet at December 31, 2023 shows equity of DKK 890.267 thousand. Income relates to licensing of the acquired intangible fixed assets and the result for the year is considered satisfactory. In the financial statements for 2022 management expected profit/loss for 2023 to be within a margin of +/- 10% compared to 2022. Profit for the year increased 15% compared to 2022 as a result of increased revenue from royalties due to increased sales by Radiometer Medical ApS in 2023. This is caused by an increase in the number of units sold with the intellectual property. Currency adjustments has slightly positivly affected the revenue from royalty. The development is considered satisfactory. The Board of Executives recommends distibution of the profit as stated under proposed distribution of profit.
22-03-2024